摘要
６５例伴乙型肝炎表面抗原（ＨＢｓＡｇ）阳性的肺结核患者，随机抽样分为保肝与对照两组，保肝组３３例，对照组３２例。经两个月标准强化抗痨，观察肝损害情况为：保肝组９．１％，对照组４３．８％，经统计学处理，Ｐ＜０．０１，表明对这类病人在强化抗痨时辅助保肝药物以预防肝损害有显著意义。
cases of HBsAg positive pulmonary tuberculosis were randomly divided into two groups: 33 cases in hepatinica treatment group and 32 cases in control group. The standard antituberculotic was administered for 2 months, the hepatic damage of the patients in the treatment group was 9.1% and in the control group was 43.8%(P<0.01). The results suggested that auxiliary hepatinica could prevent hepatic damage while potentiated antituberculotic treatment.
出处
《现代实用医学》
1995年第3期116-117,150,共3页
Modern Practical Medicine
关键词
肺结核
HBSAG阳性
强化抗痨
保肝
Pulmonary tuberculosis
Hepatitis B core antigen
Antitubercular agents.
